Insider · CIK 0001543079
Julio A. Torres
Files at TGLS (Tecnoglass Inc.), ASTS (AST SpaceMobile, Inc.). First filing Nov 12, 2024, latest Mar 11, 2025.
Where the trades landed
Last year at the 2 companies this insider has traded most, with each buy and sell on the bar it happened.
ASTS: AST SpaceMobile, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
TGLS: Tecnoglass Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 60Notable | AST SpaceMobile, Inc. | $615k 20,000 shares | -28% | +64% from low-14% from high | |
| 75Notable | Tecnoglass Inc. | $2.2M 30,520 shares | -100% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 24, 2025 | ASTS AST SpaceMobile, Inc. | AGrant or award Class A Common Stock | +801 | $0.00 | $0 | 58,239 | Jun 26, 2025 |
| Jun 6, 2025 | ASTS AST SpaceMobile, Inc. | AGrant or award Class A Common Stock | +4,810 | $0.00 | $0 | 57,438 | Jun 26, 2025 |
| Jun 6, 2025 | ASTS AST SpaceMobile, Inc. | AGrant or award Class A Common Stock | +4,810 | $0.00 | $0 | 57,438 | Jun 10, 2025 |
| Mar 10, 2025 | ASTS AST SpaceMobile, Inc. | SOpen-market sale Class A Common Stock | -20,000 | $30.73 | $615k | 52,628 | Mar 11, 2025 |
| Nov 12, 2024 | TGLS Tecnoglass Inc. | SOpen-market sale Ordinary shares | -30,520 | $72.83 | $2.2M | 0 | Nov 12, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.